quinazolines has been researched along with Chromosome-Defective Micronuclei in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eastmond, DA; Gollapudi, P; Hasegawa, LS | 1 |
Alimoghaddam, K; Ghaffari, SH; Ghanizadeh-Vesali, S; Ghavamzadeh, A; Modarressi, MH; Salmaninejad, A; Yaghmaie, M; Zekri, A | 1 |
2 other study(ies) available for quinazolines and Chromosome-Defective Micronuclei
Article | Year |
---|---|
A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors.
Topics: Aurora Kinase B; Benzamides; Cell Line; Chromosomes, Human; Flavonoids; Flavonols; Humans; Micronuclei, Chromosome-Defective; Piperazines; Polyploidy; Protein Kinase Inhibitors; Quinazolines | 2014 |
AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy.
Topics: Aneugens; Animals; Apoptosis; Aurora Kinase B; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization, Fluorescence; Male; Mice; Micronuclei, Chromosome-Defective; Organophosphates; Prostatic Neoplasms; Quinazolines; Receptors, Androgen; Xenograft Model Antitumor Assays | 2015 |